Leap Therapeutics (LPTX) PT Raised to $3.50 at Raymond James

March 2, 2021 7:40 AM EST
Get Alerts LPTX Hot Sheet
Price: $1.65 -2.37%

Rating Summary:
    5 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 13 | New: 41
Trade Now! 
Join SI Premium – FREE
Raymond James analyst David Novak raised the price target on Leap Therapeutics (NASDAQ: LPTX) to $3.50 (from $2.50) while maintaining a Outperform rating.

You May Also Be Interested In





Related Categories

Analyst PT Change